{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:28:16Z","timestamp":1762432096265,"version":"3.37.3"},"reference-count":30,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2021,6,8]]},"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1136\/ejhpharm-2021-002842","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T17:26:50Z","timestamp":1624901210000},"page":"172-176","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Availability of antidotes in Moroccan hospitals: a national survey"],"prefix":"10.1136","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0692-2036","authenticated-orcid":false,"given":"Rachid","family":"Eljaoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef","family":"Moutaouakkil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badr","family":"Adouani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmina","family":"Tadlaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Boukria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Ait El Cadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal","family":"Lamsaouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser","family":"Bousliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"2024102217112716000_30.3.172.1","unstructured":"World Health Organization . Guidelines for poison control. Available: https:\/\/www.who.int\/ipcs\/publications\/training_poisons\/guidelines_poison_control\/en\/index7.html [Accessed 22 Dec 2020]."},{"key":"2024102217112716000_30.3.172.2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/15563659709043364","article-title":"Evaluation of antidotes: activities of the International Programme on Chemical Safety","volume":"35","author":"Pronczuk de Garbino","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"key":"2024102217112716000_30.3.172.3","unstructured":"Royal College of Emergency Medicine . Royal College of emergency medicine and national poisons information service guideline on antidote availability for emergency departments, 2017. Available: https:\/\/www.rcem.ac.uk\/docs\/College%20Guidelines\/RCEM%20NPIS%20Antidote%20Guideline%20Appx%201.pdf [Accessed 01 Apr 2021]."},{"key":"2024102217112716000_30.3.172.4","unstructured":"Flomenbaum NE , Goldfrank LR , Hofman RS . Goldfrank\u2019s Toxicologic Emergencies. 8th ed. New York: McGraw-Hill, 2006: 1981."},{"key":"2024102217112716000_30.3.172.5","first-page":"21","article-title":"Inadequate stocking of antidotes in Taiwan: is it a serious problem?","volume":"38","author":"Ong","year":"2000","journal-title":"J Toxicol"},{"key":"2024102217112716000_30.3.172.6","first-page":"27","article-title":"Availability of antidotes at acute care hospitals in Ontario","volume":"165","author":"Juurlink","year":"2001","journal-title":"CMAJ"},{"key":"2024102217112716000_30.3.172.7","first-page":"103","article-title":"Availability of antidotes in hospital pharmacies in Greece","volume":"43","author":"Plataki","year":"2001","journal-title":"Vet Hum Toxicol"},{"key":"2024102217112716000_30.3.172.8","first-page":"1111","article-title":"Antidote availability in Norway","volume":"122","author":"Solheim","year":"2002","journal-title":"Tidsskr Nor Laegeforen"},{"key":"2024102217112716000_30.3.172.9","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1093\/ajhp\/60.22.2345","article-title":"Availability of antidotes in Quebec hospitals before and after dissemination of guidelines","volume":"60","author":"Bailey","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"2024102217112716000_30.3.172.10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1017\/S1481803500008058","article-title":"Antidote stocking in British Columbia hospitals","volume":"5","author":"Gorman","year":"2003","journal-title":"CJEM"},{"key":"2024102217112716000_30.3.172.11","first-page":"231","article-title":"Availability of antidotes in hospital pharmacies in the Czech Republic","volume":"52","author":"Hrub\u00fd","year":"2003","journal-title":"Ceska Slov Farm"},{"key":"2024102217112716000_30.3.172.12","first-page":"4257","article-title":"Availability of antidotes in Denmark","volume":"166","author":"Jacobsen","year":"2004","journal-title":"Ugeskr Laeger"},{"key":"2024102217112716000_30.3.172.13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1017\/S1481803500014214","article-title":"Adequacy of antidote stocking in British Columbia hospitals: the 2005 antidote stocking study","volume":"8","author":"Wiens","year":"2006","journal-title":"CJEM"},{"key":"2024102217112716000_30.3.172.14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2515\/therapie:2007038","article-title":"The availability of the antidotes in the Moroccan hospitals: a report revealing an urgency!","volume":"62","author":"Benziane","year":"2007","journal-title":"Therapie"},{"key":"2024102217112716000_30.3.172.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1584.2010.01129.x"},{"key":"2024102217112716000_30.3.172.16","doi-asserted-by":"publisher","DOI":"10.1177\/0960327111405861"},{"key":"2024102217112716000_30.3.172.17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1071\/HC12100","article-title":"Access in New Zealand to antidotes for accidental and intentional drug poisonings","volume":"4","author":"Abbott","year":"2012","journal-title":"J Prim Health Care"},{"key":"2024102217112716000_30.3.172.18","doi-asserted-by":"crossref","first-page":"s167","DOI":"10.1590\/0102-311X00016113","article-title":"Antidotes and medicines used to treat poisoning in Brazil: needs, availability and opportunities","volume":"29 Suppl 1","author":"Galv\u00e3o","year":"2013","journal-title":"Cad Saude Publica"},{"key":"2024102217112716000_30.3.172.19","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2012-201224"},{"key":"2024102217112716000_30.3.172.20","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3346\/jkms.2014.29.11.1562","article-title":"Kind and estimated stocking amount of antidotes for initial treatment for acute poisoning at emergency medical centers in Korea","volume":"29","author":"Sohn","year":"2014","journal-title":"J Korean Med Sci"},{"key":"2024102217112716000_30.3.172.21","first-page":"20","article-title":"Availability and quantity of antidotes in New Zealand","volume":"128","author":"Schep","year":"2015","journal-title":"N Z Med J"},{"key":"2024102217112716000_30.3.172.22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1590\/1516-3180.2016.00171120816","article-title":"Antidote availability in the municipality of Campinas, S\u00e3o Paulo, Brazil","volume":"135","author":"Rodrigues Fernandes","year":"2017","journal-title":"Sao Paulo Med J"},{"key":"2024102217112716000_30.3.172.23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jemermed.2019.11.016","article-title":"Availability of antidotes in Kuwait: a national audit","volume":"58","author":"Al-Taweel","year":"2020","journal-title":"J Emerg Med"},{"key":"2024102217112716000_30.3.172.24","first-page":"5","article-title":"Une centrale antidotes pour une gestion rationnelle des antidotes au Maroc","volume":"16","author":"Farouq","year":"2013","journal-title":"Toxicologie Maroc"},{"key":"2024102217112716000_30.3.172.25","doi-asserted-by":"crossref","unstructured":"Koshy S , Abahussain E . The availability of antidotes in public hospitals in Kuwait: a cross sectional survey. J Pharma Care Health Sys 2014:S1\u20132.","DOI":"10.4172\/2376-0419.S1-004"},{"key":"2024102217112716000_30.3.172.26","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.81.6.1744"},{"key":"2024102217112716000_30.3.172.27","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-015-1630-8","article-title":"Patterns of accidental deaths in Kuwait: a retrospective descriptive study from 2003-2009","volume":"15","author":"Al-Kandary","year":"2015","journal-title":"BMC Public Health"},{"key":"2024102217112716000_30.3.172.28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s13181-013-0372-1","article-title":"Antidote shortages in the USA: impact and response","volume":"11","year":"2015","journal-title":"J Med Toxicol"},{"key":"2024102217112716000_30.3.172.29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/bcpt.12897","article-title":"Antidote availability in Saudi Arabia hospitals in the Riyadh Province","volume":"122","author":"AlTamimi","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2024102217112716000_30.3.172.30","first-page":"74","article-title":"Appropriate utilization and stocking of antidotes in Qatar public hospitals","volume":"6","author":"Salem","year":"2017","journal-title":"Asia Pac J Med Toxicol"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2021-002842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:14:09Z","timestamp":1729642449000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2021-002842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,4,21]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1136\/ejhpharm-2021-002842"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2021-002842","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"type":"print","value":"2047-9956"},{"type":"electronic","value":"2047-9964"}],"subject":[],"published":{"date-parts":[[2021,6,28]]}}}